The 13 linked references in paper A. Mudunov M., M. Narimanov N., D. Safarov A., B. Dolgushin I., A. Akhundov A., I. Trofimov A., А. Мудунов М., М. Нариманов Н., Д. Сафаров А., Б. Долгушин И., А. Ахундов А., И. Трофимов А. (2018) “Обзор возможностей регионарной интраартериальной химиотерапии в лечении плоскоклеточного рака полости носа и придаточных пазух // Review of the possibilities of regional intra-arterial chemotherapy in the treatment of squamous cell carcinoma of the nasal cavity and paranasal sinuses” / spz:neicon:ogsh:y:2018:i:1:p:56-61

  1. Ock C.Y., Keam B., Kim T.M. et al. Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservation. Korean J Intern Med 2016;31(3):570–8. DOI: 10.3904/ kjim.2015.020.
  2. Reyes-Gibby C.C., Anderson K.O., Merriman K.W. et al. Survival patterns in squamous cell carcinoma of the head and neck: pain as an independent prognostic factor for survival. J Pain 2014;15(10):1015–22. DOI: 10.1016/j.jpain.2014.07.003.
  3. Fernström E., Nyman J., Hammerlid E. et al. Results of preoperative chemoradiotherapy for patients with advanced cancer of the nasal cavity and paranasal sinuses. Acta Otolaryngol 2017;137(12):1292–300. DOI: 10.1080/00016489.2017.1357081.
  4. Bristol I.J., Ahamad A., Garden A.S. et al. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 2007;68(3):719–30. DOI: 10.1016/j.ijrobp.2007.01.032.
  5. Dimery I.W., Hong W.K. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993;85(2):95–111. DOI: 10.1093/ jnci/85.2.95.
  6. Sanders I.W., Haslet K., Correa P. et al. Sequential TPF chemotherapy followed by concurrent chemoradiotherapy in locally advanced head and neck cancer – a retrospective analysis of toxicity and outcomes. Scottish Med J 2014;59(1): 50–5. DOI: 10.1177/0036933013518153.
  7. Lorch J.H., Goloubeva O., Haddad R.I. et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 2011;12(2):153–9. DOI: 10.1016/S1470-2045(10)70279-5.
  8. Kim J.H., Lee Y.S., Chung Y.-S. et al. Treatment outcomes of concurrent chemoradiotherapy for locally advanced sinonasal squamous cell carcinoma: A single-institution study. Acta Otolaryngol 2015;135(11):1189–95. DOI: 10.3109/00016489.2015.1061697.
  9. Garavello W., Ciardo A., Spreafico R., Gaini R.M. Risk factors for distant metastases in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2006;132(7):762–6. DOI: 10.1001/ archotol.132.7.762.
  10. Foote R.L., Kasperbauer J.L., Okuno S.H. et al. A pilot study of high-dose intraarterial cisplatin chemotherapy with concomitant accelerated radiotherapy for patients with previously untreated T4 and selected patients with T3N0-N3M0 squamous cell carcinoma of the upper aerodigestive tract. Cancer 2005;103(3):559–68. DOI: 10.1002/cncr.20803.
  11. Rabbani A., Hinerman R.W., Schmal- fuss I.M. et al. Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck. Am J Clin Oncol 2007;30(3):283–6. DOI: 10.1097/01.coc.0000258118.38177.74.
  12. Homma А., Sakashita T., Yoshida D. et. al. Superselective intra-arterial cisplatin infusion and concomitant radiotherapy for maxillary sinus cancer. Br J Cancer 2013;109:2980–6. DOI: 10.1038/ bjc.2013.663.
  13. Furusaka T., Asakawa T., Tanaka A., Ikeda M. Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer. Acta Otolaryngol 2012;132(10):1108–14. DOI: 10.3109/00016489.2012.684702.